(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 6.67% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 17%.
Rxsight's revenue in 2026 is $127,478,000.On average, 11 Wall Street analysts forecast RXST's revenue for 2026 to be $5,458,970,829, with the lowest RXST revenue forecast at $5,173,334,227, and the highest RXST revenue forecast at $5,698,657,195. On average, 11 Wall Street analysts forecast RXST's revenue for 2027 to be $6,009,959,695, with the lowest RXST revenue forecast at $5,545,903,708, and the highest RXST revenue forecast at $6,437,586,666.
In 2028, RXST is forecast to generate $6,543,975,951 in revenue, with the lowest revenue forecast at $5,841,889,462 and the highest revenue forecast at $7,306,915,455.